Leason Ellis and Thirteen of the Firm’s Lawyers Recognized in IAM Patent 1000 for 2026

Each year, IAM evaluates firms based on client feedback, peer reviews, and independent market research. In its 2026 edition, IAM recognized that our patent practice's "differentiation lies in the range of technologies it covers under one roof, from life sciences, medical devices and chemistry to software, AI and industrial systems, as well as its ability to handle both contentious and non-contentious matters in a joined-up way. The firm is also well placed for Asia-facing work through its China and Japan groups, giving overseas companies and research institutions direct access to coordinated US advice.” Notably, thirteen of our attorneys were individually recognized for their contributions: Elizabeth Barnhard, Susie Cheng, Ph.D., Ralph Crispino, Michael Davitz, M.D., Edward Ellis, Brian Gummow, Ph.D., Jordan Garner, Melvin Garner, James Haley, Ph.D., Robert Isackson, David Leason, Yuval Marcus, and Karen Mangasarian, Ph.D. We’re honored by our team's continued recognition and proud that Leason Ellis remains a go-to firm for sophisticated, strategic, and personalized patent counsel.